Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMRN | ARWR | TECH | ||
| Company | Biomarin Pharmaceuticals | Arrowhead Pharma | Bio-Techne Corp | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 59.24 | 86.84 | 71.90 | ||
| High | 59.35 | 87.50 | 71.94 | ||
| Low | 58.61 | 85.06 | 71.58 | ||
| Latest | 59.33 | 85.60 | 71.60 | ||
| Change | +0.46 | -1.18 | -0.17 | ||
| % Change | +0.78% | -1.36% | -0.24% | ||
| Volume | 1,937,600 | 1,825,200 | 2,065,700 | ||
| 20-Day Average Volume | 1,654,560 | 3,251,815 | 5,891,335 | ||
| Previous Close | 58.87 | 86.78 | 71.77 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 59.00 | 79.79 | 71.29 | ||
| 20-Day Raw Stochastic | 68.40% | 61.38% | 68.10% | ||
| 20-Day Relative Strength | 56.14 | 57.97 | 70.24 | ||
| Weighted Alpha | +3.96 | +267.65 | +27.10 | ||
| Today's Opinion | 72% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 72% Buy | ||
| Last Month's Opinion | 24% Buy | 96% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.44% since 07/17/26 | +15.21% since 07/17/26 | -0.72% since 07/17/26 | ||
| Low | 57.42 on 07/23/26 | 71.00 on 07/20/26 | 71.45 on 07/21/26 | ||
| High | 59.98 on 07/22/26 | 95.49 on 07/22/26 | 72.11 on 07/23/26 | ||
| 1-Month | |||||
| %Chg | +3.49% since 06/24/26 | +7.25% since 06/24/26 | +21.61% since 06/24/26 | ||
| Low | 56.40 on 06/25/26 | 69.88 on 07/15/26 | 70.08 on 06/25/26 | ||
| High | 60.67 on 07/08/26 | 95.49 on 07/22/26 | 72.12 on 07/17/26 | ||
| 3-Month | |||||
| %Chg | +11.56% since 04/24/26 | +15.82% since 04/24/26 | +32.14% since 04/24/26 | ||
| Low | 49.26 on 05/18/26 | 68.97 on 04/29/26 | 43.19 on 05/15/26 | ||
| High | 60.67 on 07/08/26 | 95.49 on 07/22/26 | 72.12 on 07/17/26 | ||
| 6-Month | |||||
| %Chg | +5.55% since 01/23/26 | +27.67% since 01/23/26 | +5.05% since 01/23/26 | ||
| Low | 49.26 on 05/18/26 | 54.02 on 03/13/26 | 43.19 on 05/15/26 | ||
| High | 66.28 on 02/24/26 | 95.49 on 07/22/26 | 72.12 on 07/17/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,467,540 | 12,057,359 | 11,210,340 | ||
| Shares Outstanding, K | 193,284 | 140,857 | 156,569 | ||
| Annual Sales | 3,221,250,000 | 829,450,000 | 1,219,640,000 | ||
| Annual Net Income | 348,900,000 | -1,630,000 | 73,400,000 | ||
| Last Quarter Sales | 766,210,000 | 73,740,000 | 311,420,000 | ||
| Last Quarter Net Income | 105,530,000 | -132,730,000 | 51,050,000 | ||
| 60-Month Beta | 0.24 | 1.26 | 1.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.76 on 05/04/26 | -0.93 on 05/07/26 | 0.53 on 05/06/26 | ||
| Earnings Date | 08/03/26 | 08/04/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | 0.080 on 05/18/26 | ||
| Next Ex-Dividends Date | N/A | N/A | 05/18/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 29.00 | 0.00 | 41.25 | ||